Organigram Holdings Inc. (NASDAQ:OGI) Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. reduced its stake in Organigram Holdings Inc. (NASDAQ:OGI) by 28.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 29,000 shares of the company’s stock after selling 11,611 shares during the quarter. Vontobel Holding Ltd.’s holdings in Organigram were worth $46,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Tidal Investments LLC increased its position in shares of Organigram by 8.3% in the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after purchasing an additional 149,171 shares during the last quarter. Clear Harbor Asset Management LLC boosted its stake in Organigram by 37.4% during the 4th quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company’s stock worth $72,000 after purchasing an additional 12,250 shares during the period. Finally, Toronto Dominion Bank boosted its stake in Organigram by 803.7% during the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after purchasing an additional 14,876 shares during the period. 34.63% of the stock is currently owned by institutional investors and hedge funds.

Organigram Stock Performance

OGI stock opened at $1.31 on Friday. Organigram Holdings Inc. has a one year low of $1.24 and a one year high of $2.91. The stock has a market capitalization of $165.35 million, a PE ratio of -3.45 and a beta of 1.00. The company has a fifty day moving average of $1.53 and a 200-day moving average of $1.65.

Organigram (NASDAQ:OGI) last announced its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative net margin of 31.69% and a negative return on equity of 8.59%. Equities analysts forecast that Organigram Holdings Inc. will post -0.19 earnings per share for the current fiscal year.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.